Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting

Journal of Perinatology volume 32, pages 425–430 (2012)Cite this article

Abstract

Objective:

Each year in the US ∼50 000 neonates receive inpatient pharmacotherapy for the treatment of neonatal abstinence syndrome (NAS). The objective of this study is to compare the safety and efficacy of a traditional inpatient only approach with a combined inpatient and outpatient methadone treatment program.

Study Design:

Retrospective review (2007 to 2009). Infants were born to mothers maintained on methadone in an antenatal substance abuse program. All infants received methadone for NAS treatment as inpatient. Methadone weaning for the traditional group (75 patients) was inpatient, whereas the combined group (46 patients) was outpatient.

Result:

Infants in the traditional and combined groups were similar in demographics, obstetrical risk factors, birth weight, gestational age (GA) and the incidence of prematurity (34 and 31%). Hospital stay was shorter in the combined than in the traditional group (13 vs 25 days; P<0.01). Although the duration of treatment was longer for infants in the combined group (37 vs 21days, P<0.01), the cumulative methadone dose was similar (3.6 vs 3.1 mg kg−1, P=0.42). Follow-up information (at least 3 months) was available for 80% of infants in the traditional and 100% of infants in the combined group. All infants in the combined group were seen ⩽72 h from hospital discharge. Breastfeeding was more common among infants in the combined group (24 vs 8% P<0.05). Following discharge there were no differences between the two groups in hospital readmissions for NAS. Prematurity (34 to 36 weeks GA) was the only predictor for hospital readmission for NAS in both groups (P=0.02, OR 5). Average hospital cost for each infant in the combined group was $13 817 less than in the traditional group.

Conclusion:

A combined inpatient and outpatient methadone treatment in the management of NAS decreases hospital stay and substantially reduces cost. Additional studies are needed to evaluate the potential long-term benefits of the combined approach on infants and their families.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kuschel C . Managing drug withdrawal in the newborn infant. Semin Fetal Neonatal Med 2007; 12: 127–133.

    Article  PubMed  Google Scholar 

  2. Jones H, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320–2331.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Finnegan LP, Connaughton Jr JF, Kron RE, Emich JP . Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2: 141–158.

    CAS  PubMed  Google Scholar 

  4. Kellogg A, Rose CH, Harms RH, Watson WJ . Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol 2011; 204: 259.e104.

    Article  Google Scholar 

  5. American academy of pediatrics (AAP) committee on drugs. Neonatal drug withdrawal. Pediatrics 1998; 101: 1079–1088.

  6. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007; 87: 131–138.

    Article  PubMed  Google Scholar 

  7. Dryden C, Young D, Hepburn M, Mactier H . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009; 116: 665–671.

    Article  CAS  PubMed  Google Scholar 

  8. Svikis CS, Golden AS, Huggins GR, Pickens RW, McCaul ME, Velez ML et al. Cost-effectiveness of treatment for drug-abusing pregnant women. Drug Alcohol Depend 1997; 45: 105–113.

    Article  CAS  PubMed  Google Scholar 

  9. Hulse GK, Milne E, English DR, Holman CDJ . Assessing the relationship between maternal opiate use and neonatal mortality. Addiction 1998; 93: 1033–1042.

    Article  CAS  PubMed  Google Scholar 

  10. Arlettaz R, Kashiwagi M, Das-Kundu S, Fauchere J, Lang A, Bucher HU . Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand 2005; 84: 145–150.

    Article  PubMed  Google Scholar 

  11. Burns L, Mattick RP, Lim K, Wallace C . Methadone in pregnancy: treament retention and neonatal outcomes. Addiction 2007; 102: 264–270.

    Article  PubMed  Google Scholar 

  12. Mattick RP, Breen C, Kimber J, Davoli M . Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; 3: CD002209.

    Google Scholar 

  13. Johnson K, Gerada C, Greenough A . Substance misuse during pregnancy. Brit J Psych 2003; 183: 187–189.

    Article  CAS  Google Scholar 

  14. Hunt RW, Tzioumi D, Collins E, Jeffery HE . Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum Dev 2008; 84: 29–35.

    Article  CAS  PubMed  Google Scholar 

  15. McCarthy JJ, Leamon MH, Parr MS, Anania B . High dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 2005; 193: 606–610.

    Article  CAS  PubMed  Google Scholar 

  16. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI . A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care 2005; 5: 265–272.

    Article  PubMed  Google Scholar 

  17. Langenfeld S, Birkenfeld L, Herkenrath P, Müller C, Hellmich M, Theisohn M . Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops. Drug Alcohol Depend 2005; 77: 31–36.

    Article  CAS  PubMed  Google Scholar 

  18. Isemann B, Meinzen-Derr J, Akinibi H . Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. J Perinatol 2011; 31: 25–29.

    Article  CAS  PubMed  Google Scholar 

  19. O’Grady MJ, Hopewell J, White MJ . Management of neonatal abstinence syndrome: a national survey and review of practice. Arch Dis Child Fetal Neonatal Ed 2009; 94: F249–F252.

    Article  PubMed  Google Scholar 

  20. Abrahams RR, Kelly SA, Payne S, Thiessen PN, Mackintosh J, Janssen PA . Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician 2007; 53: 1722–1730.

    PubMed  PubMed Central  Google Scholar 

  21. Velez M, Jansson LM . The opioid dependent mother and newborn dyad: non-pharmacologic care. J Addict Med 2008; 2: 113–120.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Saiki T, Lee S, Hannam S, Greenough A . Neonatal abstinence syndrome—postnatal ward versus neonatal unit management. Eur J Pediatr 2010; 169: 95–98.

    Article  PubMed  Google Scholar 

  23. Oei J, Feller JM, Lui K . Coordinated outpatient care of the narcotic-dependent infant. J Paediatr Child Health 2001; 37: 266–270.

    Article  CAS  PubMed  Google Scholar 

  24. Jansson LM, Velez M, Harrow C . The opioid exposed newborn: assessment and pharmacologic management. J Opioid Manag 2009; 5: 47–55.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Chasnoff I, Burns W . The moro reaction: a scoring system for neonatal narcotic withdrawal. Dev Med Child Neurol 1984; 26: 484–486.

    Article  CAS  PubMed  Google Scholar 

  26. Chasnoff IJ . Newborn infants with drug withdrawal smptoms. Pediatr Rev 1988; 9: 273–277.

    Article  CAS  PubMed  Google Scholar 

  27. Kwan P, Brodie MJ . Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 2004; 45: 1141–1149.

    Article  CAS  PubMed  Google Scholar 

  28. Soepatmi S . Developmental outcomes of children of mothers dependent on heroin or heroin/methadone during pregnancy. Acta Paediatr Suppl 1994; 404: 36–39.

    Article  CAS  PubMed  Google Scholar 

  29. Selleck CS, Redding BA . Knowledge and attitudes of registered nurses toward perinatal substance abuse. JOGNN 1988; 27: 70–77.

    Article  Google Scholar 

  30. Serane VT, Kurian O . Neonatal abstinence syndrome. Indian J Pediatr 2008; 75: 911–914.

    Article  PubMed  Google Scholar 

  31. Doberczak TM, Kandall SR, Wilets I . Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991; 118: 933–937.

    Article  CAS  PubMed  Google Scholar 

  32. American Academy of Pediatrics. Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776–789.

    Article  Google Scholar 

  33. Abdel-Latif ME, Pinner J, Clews S, Cook F, Lui K, Oei J . Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2005; 117: e1163–e1169.

    Article  Google Scholar 

  34. Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics 2008; 121: 106–114.

    Article  PubMed  Google Scholar 

  35. Jackson L, Ting A, Mckay S, Galea P, Skeoch C . A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed 2004; 39: F300–F304.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatal-Perinatal Medicine, Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH, USA

    C H Backes, D Gardner, C A Nankervis, P J Giannone & L Cordero

  2. College of Osteopathic Medicine, Ohio University, Athens, OH, USA

    C R Backes

Authors
  1. C H Backes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C R Backes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Gardner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C A Nankervis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P J Giannone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Cordero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L Cordero.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Backes, C., Backes, C., Gardner, D. et al. Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting. J Perinatol 32, 425–430 (2012). https://doi.org/10.1038/jp.2011.114

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2011.114

Keywords

This article is cited by

Search

Advanced search

Quick links